RCM
TNGX icon

RA Capital Management’s Tango Therapeutics TNGX Stock Holding History

RA Capital Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,000,000
Closed -$16.8M – 86
2025
Q3 		$16.8M Hold
2,000,000
– – 0.21% 45
2025
Q2 		$10.2M Buy
+2,000,000
New +$4.95M 0.17% 45
2022
Q2 		– Sell
-2,250,000
Closed -$17.1M – 99
2022
Q1 		$17.1M Hold
2,250,000
– – 0.37% 56
2021
Q4 		$24.6M Hold
2,250,000
– – 0.43% 57
2021
Q3 		$29.1M Buy
2,250,000
+1,000,000
+80% +$12M 0.4% 53
2021
Q2 		$14.2M Hold
1,250,000
– – 0.23% 62
2021
Q1 		$13.9M Hold
1,250,000
– – 0.21% 61
2020
Q4 		$14.3M Hold
1,250,000
– – 0.2% 63
2020
Q3 		$12.9M Buy
+1,250,000
New +$12.8M 0.24% 55

Other funds holding TNGX

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RA Capital Management's TNGX Position: Q4 2025 in Review

RA Capital Management sold out of Tango Therapeutics (TNGX) in Q4 2025, closing a stake of 2,000,000 shares — an estimated $16.8M sold.

RA Capital Management first reported a position in TNGX in Q3 2020 and held it in 9 quarters. The position peaked at $29.1M in Q3 2021. 170 funds tracked by Wall St. Rank hold TNGX as of Q4 2025.

  • RA Capital Management reported no remaining Tango Therapeutics position as of Q4 2025 after selling out during the quarter.
  • RA Capital Management sold 2,000,000 Tango Therapeutics shares in Q4 2025, an estimated $16.8M.
  • RA Capital Management first reported a position in Tango Therapeutics in Q3 2020 and held it in 9 quarters.
  • RA Capital Management's Tango Therapeutics position peaked at $29.1M in Q3 2021.
  • 170 funds tracked by Wall St. Rank held Tango Therapeutics as of Q4 2025.

Based on RA Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.